---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-052210"
form_type: "8-K"
ticker: "INDV"
cik: "0001625297"
company_name: "Indivior Pharmaceuticals, Inc."
filed_at: "2025-11-14T23:59:59+00:00"
generated_at: "2026-05-16T19:51:48.611494+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Indivior proposes re-domestication from UK to Delaware; shareholder vote set for Dec 11, 2025

## Summary
- Scheme circular filed: EGM on Dec 11, 2025 to vote on re-domestication via scheme of arrangement.
- New holding company would be Indivior Pharmaceuticals, Inc. (Delaware); shares to trade on Nasdaq.
- Court approval and shareholder vote required; SEC registration exemption under Section 3(a)(10).
- Indivior shares expected to cease trading on Nasdaq before effective date; new shares commence same day.
- Board unanimously recommends voting in favor.

## SEC filing metadata
- accession: 0001628280-25-052210
- form_type: 8-K
- ticker: INDV
- cik: 0001625297
- company_name: Indivior Pharmaceuticals, Inc.
- filed_at: 2025-11-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625297/000162828025052210/0001628280-25-052210-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625297/000162828025052210/indv-20251114.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-052210
- JSON: https://secwatch.observer/filing/0001628280-25-052210.json
- Plain text: https://secwatch.observer/filing/0001628280-25-052210.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.